PMC Links for Books (Select 4855908) - PMC

Result Filters

Links from Books

Items: 11

Select item 69958131.

Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008–2017

Hyun Kyung Kim, Dae Yeon Kim, Eun-Kee Bae, Dong Wook Kim

J Korean Med Sci. 2020 Feb 3; 35(4): e17. Published online 2019 Dec 23. doi: 10.3346/jkms.2020.35.e17

PMCID:: PMC6995813

Abstract Article PDF–926K

Select item 64207762.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Antiepileptic Drugs: An Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS)

Eric P. Borrelli, Erica Y. Lee, Andrew M. Descoteaux, Stephen J. Kogut, Aisling R. Caffrey

Epilepsia. Author manuscript; available in PMC 2019 Dec 1.

Published in final edited form as: Epilepsia. 2018 Dec; 59(12): 2318–2324. Published online 2018 Nov 5. doi: 10.1111/epi.14591

PMCID:: PMC6420776

Abstract Article PDF–417K

Select item 52935063.

The HLA-A*31:01 allele: influence on carbamazepine treatment

Vincent Lai Ming Yip, Munir Pirmohamed

Pharmgenomics Pers Med. 2017; 10: 29–38. Published online 2017 Jan 31. doi: 10.2147/PGPM.S108598

PMCID:: PMC5293506

Abstract Article PDF–2.8M

Select item 52010654.

Antiepileptic Drugs-induced Stevens–Johnson syndrome: A case Series

Bhavi S. Trivedi, Nishita H. Darji, Supriya D. Malhotra, Pankaj R. Patel

J Basic Clin Pharm. December 2016-February 2017; 8(1): 42–44. doi: 10.4103/0976-0105.195130

PMCID:: PMC5201065

Abstract Article PDF–203K

Select item 50420725.

Long‐term efficacy and safety of adjunctive extended‐release oxcarbazepine (Oxtellar XR^®) in adults with partial‐onset seizures

S. S. Chung, J. K. Johnson, S. T. Brittain, P. Baroldi

Acta Neurol Scand. 2016 Feb; 133(2): 124–130. Published online 2015 Aug 6. doi: 10.1111/ane.12467

PMCID:: PMC5042072

Abstract Article PDF–226K

Select item 44462356.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 41253107.

The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review

Nahoko Kaniwa, Yoshiro Saito

Ther Adv Drug Saf. 2013 Dec; 4(6): 246–253. doi: 10.1177/2042098613499791

PMCID:: PMC4125310

Abstract Article PDF–1011K

Select item 40335718.

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial

JA French, P Baroldi, ST Brittain, JK Johnson

Acta Neurol Scand. 2014 Mar; 129(3): 143–153. Published online 2013 Dec 21. doi: 10.1111/ane.12207

PMCID:: PMC4033571

Abstract Article PDF–228K

Select item 36542449.

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy Davern, Jose Serrano, Hongqiu Yang, James Rochon, for the Drug Induced Liver Injury Network (DILIN)

Gastroenterology. Author manuscript; available in PMC 2013 May 15.

Published in final edited form as: Gastroenterology. 2008 Dec; 135(6): 1924–1934.e4. Published online 2008 Sep 17. doi: 10.1053/j.gastro.2008.09.011